272 related articles for article (PubMed ID: 8878583)
1. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
2. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
[TBL] [Abstract][Full Text] [Related]
3. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
[TBL] [Abstract][Full Text] [Related]
6. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Feb; 40(2):362-6. PubMed ID: 8834881
[TBL] [Abstract][Full Text] [Related]
7. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
[TBL] [Abstract][Full Text] [Related]
9. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
[TBL] [Abstract][Full Text] [Related]
10. Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.
Pankuch GA; Kelly LM; Lin G; Bryskier A; Couturier C; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Oct; 47(10):3270-4. PubMed ID: 14506040
[TBL] [Abstract][Full Text] [Related]
11. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
12. Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
Davies TA; Ednie LM; Hoellman DM; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Jul; 44(7):1894-9. PubMed ID: 10858350
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
[TBL] [Abstract][Full Text] [Related]
14. Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.
Pankuch GA; Davies TA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2002 Jan; 46(1):42-6. PubMed ID: 11751109
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
[TBL] [Abstract][Full Text] [Related]
17. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D
Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
Traub WH; Leonhard B
Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790
[TBL] [Abstract][Full Text] [Related]
20. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
